Evidence map›Paper›PMID 36613449›Full record

ArticleInternational journal of molecular sciences2022

New Affordable Methods for Large-Scale Isolation of Major Olive Secoiridoids and Systematic Comparative Study of Their Antiproliferative/Cytotoxic Effect on Multiple Cancer Cell Lines of Different Cancer Origins.

Aikaterini Papakonstantinou, Petrina Koumarianou, Aimilia Rigakou, Panagiotis Diamantakos, Efseveia Frakolaki, Niki Vassilaki, Evangelia Chavdoula, Eleni Melliou, Prokopios Magiatis, Haralabia Boleti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The Olive Oil PhenolicNutrients · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aikaterini PapakonstantinouIntracellular Parasitism Laboratory, Microbiology Department, Hellenic Pasteur Institute, 11521 Athens, Greece.
Petrina KoumarianouIntracellular Parasitism Laboratory, Microbiology Department, Hellenic Pasteur Institute, 11521 Athens, Greece.
Aimilia RigakouLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Panagiotis DiamantakosLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Efseveia FrakolakiMolecular Virology Laboratory, Microbiology Department, Hellenic Pasteur Institute, 11521 Athens, Greece.
Niki VassilakiMolecular Virology Laboratory, Microbiology Department, Hellenic Pasteur Institute, 11521 Athens, Greece.ORCID 0000-0001-7992-3438
Evangelia ChavdoulaBiomedical Research Division, Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, 45110 Ioannina, Greece.
Eleni MelliouLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Prokopios MagiatisLaboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0002-0399-5344
Haralabia BoletiIntracellular Parasitism Laboratory, Microbiology Department, Hellenic Pasteur Institute, 11521 Athens, Greece.
National and Kapodistrian University of Athens · GRPasteur Hellenic Institute · GR

Funding

European Social Fund- ESF through the Operational Programme «Human Resources Development, Education and Lifelong Learning 2014-2020» in the context of the project "In vitro study of anticancer properties of polyphenols isolated from greek olive MIS 5048983
6 · The paper itself

Abstract

Olive oil phenols (OOPs) are associated with the prevention of many human cancers. Some of these have been shown to inhibit cell proliferation and induce apoptosis. However, no systematic comparative study exists for all the investigated compounds under the same conditions, due to difficulties in their isolation or synthesis. Herein are presented innovative methods for large-scale selective extraction of six major secoiridoids from olive oil or leaves enabling their detailed investigation. The cytotoxic/antiproliferative bioactivity of these six compounds was evaluated on sixteen human cancer cell lines originating from eight different tissues. Cell viability with half-maximal effective concentrations (EC50) was evaluated after 72 h treatments. Antiproliferative and pro-apoptotic effects were also assessed for the most bioactive compounds (EC50 ≤ 50 μM). Oleocanthal (1) showed the strongest antiproliferative/cytotoxic activity in most cancer cell lines (EC50: 9−20 μM). The relative effectiveness of the six OOPs was: oleocanthal (1) > oleuropein aglycone (3a,b) > ligstroside aglycone (4a,b) > oleacein (2) > oleomissional (6a,b,c) > oleocanthalic acid (7). This is the first detailed study comparing the bioactivity of six OOPs in such a wide array of cancer cell lines, providing a reference for their relative antiproliferative/cytotoxic effect in the investigated cancers.

Indexed as

Antineoplastic AgentsNeoplasmsOleaAldehydesCell LineCyclopentane MonoterpenesHumansIridoidsOlive OilPhenolsAldehydesAntineoplastic AgentsCyclopentane MonoterpenesIridoidsoleocanthalOlive OilPhenolsantiproliferative bioactivitycytotoxic bioactivityhealth protectionhuman cancer cellsoleaceinoleocanthalolive oil phenolsolive secoiridoidspro-apoptotic effect

Identifiers

PMID36613449
PMCPMC9820430
OpenAlexW4313435977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.